These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3732290)

  • 1. Successful treatment of acute myocardial ischaemia with teopranitol--a novel organic nitrate.
    Thiemermann C; Smith EF; Schrör K
    Eur Heart J; 1986 May; 7(5):418-24. PubMed ID: 3732290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
    Schrör K; Thiemermann C
    Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia.
    Gallenkämper W; Rücker W; Schrör K
    Br J Pharmacol; 1984 Apr; 81(4):575-81. PubMed ID: 6547067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
    Ogletree ML; Lefer AM; Smith JB; Nicolaou KC
    Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
    Schrör K; Thiemermann C; Ney P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs.
    Heng MK; Singh BN; Norris RM; John MB; Elliot R
    J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
    Thiemermann C; Ney P; Schrör K
    Eur J Pharmacol; 1988 Oct; 155(1-2):57-67. PubMed ID: 2977337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
    J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    Brezinski ME; Darius H; Lefer AM
    Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog.
    Saliba MJ; Covell JW; Bloor CM
    Am J Cardiol; 1976 Mar; 37(4):599-604. PubMed ID: 1258797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of exaprolol (MG 8823) on epicardial ST-segment changes in a feline model of acute myocardial ischaemia.
    Parratt JR; Udvary E
    Br J Pharmacol; 1983 Sep; 80(1):95-105. PubMed ID: 6652377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.
    Burke SE; Lefer AM; Smith GM; Smith JB
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6681711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood flow and ultrastructure in ischemic myocardium of cats given dexamethasone.
    Spath JA; Barsotti RJ
    Am J Physiol; 1982 Jan; 242(1):H55-61. PubMed ID: 7058914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of propranolol on myocardial perfusion and metabolism during acute regional ischaemia.
    Fox KM; Selwyn AP; Welman E
    Clin Cardiol; 1980; 3(1):47-50. PubMed ID: 7379376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of the ischaemic myocardium from reperfusion injury by defibrotide and its possible mechanism of action.
    Thiemermann C; Ney P; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S19-22. PubMed ID: 3248105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G
    Thromb Res; 1985 Apr; 38(1):71-81. PubMed ID: 3890260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.